The immunobiology of Leishmania braziliensis infection

Frontiers in Immunology

Volumn 3, Issue JUN, 2012, Pages

  De Oliveira, Camila I ^a,b   Brodskyn, Claudia I ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Institute de Investigação em Imunologia iii   (Brazil)

Author keywords

Animal models; Human adaptive immunology; Innate immunity; Leishmania braziliensis

Indexed keywords

EID: 84874158652     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00145     Document Type: Review

References (89)

1. Afonso, L., Borges, V. M., Cruz, H., Ribeiro-Gomes, F. L., DosReis, G. A., Dutra, A. N., Clarencio, J., de Oliveira, C. I., Barral, A., Barral-Netto, M., and Brodskyn, C. I. (2008). Interactions with apoptotic but not with necrotic neutrophils increase parasite burden in human macrophages infected with Leishma-nia amazonensis. J. Leukoc. Biol. 84, 389-396.
2. Anderson, C. F., Oukka, M., Kuchroo, V. J., and Sacks, D. (2007). CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204, 285-297.
3. Antonelli, L. R., Dutra, W. O., Almeida, R. P., Bacellar, O., and Gollob, K. J. (2004). Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregula-tion. Clin. Exp. Immunol. 136, 341-348.
4. Antonelli, L. R., Dutra, W. O., Almeida, R. P., Bacellar, O., Carvalho, E. M., and Gollob, K. J. (2005). Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis. Immunol. Lett. 101, 226-230.
5. Bafica, A., Oliveira, F., Freitas, L. A., Nascimento, E. G., and Barral, A. (2003). American cutaneous leishmaniasis unresponsive to antimo-nial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline. Int. J. Dermatol. 42, 203-207.
6. Barral, A., Barral-Netto, M., Almeida, R., de Jesus, A. R., Grimaldi, G. Jr., Netto, E. M., Santos, I., Bacellar, O., and Carvalho, E. M. (1992). Lym-phadenopathy associated with Leish-mania braziliensis cutaneous infection. Am. J. Trop. Med. Hyg. 47, 587-592.
7. Barral, A., Guerreiro, J., Bomfim, G., Correia, D., Barral-Netto, M., and Carvalho, E. M. (1995a). Lym-phadenopathy as the first sign of human cutaneous infection by Leish-mania braziliensis. Am. J. Trop. Med. Hyg. 53,256-259.
8. Barral, A., Petersen, E. A., Sacks, D. L., and Neva, F. A. (1983). Late meta-static Leishmaniasis in the mouse. A model for mucocutaneous disease. Am. J. Trop. Med. Hyg. 32, 277-285.
9. Barral, A., Teixeira, M., Reis, P., Vin-has, V., Costa, J., Lessa, H., Bitten-court, A. L., Reed, S., Carvalho, E. M., and Barral-Netto, M. (1995b). Transforming growth factor-beta in human cutaneous leishmaniasis. Am. J. Pathol. 147, 947-954.
10. Barral-Netto, M., Barral, A., Brownell, C.E., Skeiky, Y. A., Ellingsworth, L. R., Twardzik, D. R., and Reed, S. G. (1992). Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science 257, 545-548.
11. Belkaid, Y., Hoffmann, K. F., Mendez, S., Kamhawi, S., Udey, M. C., Wynn, T. A., and Sacks, D. L. (2001). The role of interleukin (IL)-10 in the persistence of Leishma-nia major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194, 1497-1506.
12. Belkaid, Y., Piccirillo, C. A., Mendez, S., Shevach, E. M., and Sacks, D. L. (2002). CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502-507.
13. Bezerra, H. S., and Teixeira, M. J. (2001). Effect of Lutzomyia whit-mani (Diptera: Psychodidae) salivary gland lysates on Leishmania (Vian-nia) braziliensis infection in BALB/c mice. Mem. Inst. Oswaldo Cruz. 96, 349-351.
14. Bittar, R. C., Nogueira, R. S., Vieira-Goncalves, R., Pinho-Ribeiro, V., Mattos, M. S., Oliveira-Neto, M. P., Coutinho, S. G., and Da-Cruz, A. M. (2007). T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Vian-nia) braziliensis. Mem. Inst. Oswaldo Cruz. 102, 625-630.
15. Boaventura, V. S., Santos, C. S., Cardoso, C. R., de Andrade, J., Dos Santos, W. L., Clarencio, J., Silva, J. S., Borges, V. M., Barral-Netto, M., Brodskyn, C. I., and Barral, A. (2010). Human mucosal leishmani-asis: neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines. Eur. J. Immunol. 40,2830-2836.
16. Bomfim, G., Andrade, B. B., Santos, S., Clarencio, J., Barral-Netto, M., and Barral, A. (2007). Cellular analysis of cutaneous leishmaniasis lym-phadenopathy: insights into the early phases of human disease. Am. J. Trop. Med. Hyg. 77, 854-859.
17. Bottrel, R. L., Dutra, W. O., Martins, F. A., Gontijo, B., Carvalho, E., Barral-Netto, M., Barral, A., Almeida, R. P., Mayrink, W., Locksley, R., and Gollob, K. J. (2001). Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect. Immun. 69, 3232-3239.
18. Brodskyn, C. I, Barral, A., Boaventura, V., Carvalho, E., and Barral-Netto, M. (1997). Parasite-driven in vitro human lymphocyte cyto-toxicity against autologous infected macrophages from mucosal leishmaniasis. J. Immunol. 159, 4467-4473.
19. Campanelli, A. P., Roselino, A. M., Cavassani, K. A., Pereira, M. S., Mor-tara, R. A., Brodskyn, C.I., Goncalves, H. S., Belkaid, Y., Barral-Netto, M., Barral, A., and Silva, J. S. (2006). CD4+ CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J. Infect. Dis. 193, 1313-1322.
20. Carvalho, L. P., Pearce, E. J., and Scott, P. (2008). Functional dichotomy of dendritic cells following interaction with Leishmania braziliensis: infected cells produce high levels of TNF-alpha, whereas bystander dendritic cells are activated to promote T cell responses. J. Immunol. 181, 6473-6480.
21. Childs, G. E., Lightner, L. K., McKinney, L., Groves, M. G., Price, E. E., and Hendricks, L. D. (1984). Inbred mice as model hosts for cutaneous leishmaniasis. I. Resistance and susceptibility to infection with Leishmania braziliensis, L. mexicana, and L. aethiopica. Ann. Trop. Med. Parasitol. 78, 25-34.
22. Clarencio, J., de Oliveira, C. I., Bomfim, G., Pompeu, M. M., Teixeira, M. J., Barbosa, T. C., Souza-Neto, S., Carvalho, E. M., Brodskyn, C., Barral, A., and Barral-Netto, M. (2006). Characterization of the T-cell receptor Vbeta repertoire in the human immune response against Leishmania parasites. Infect. Immun. 74, 4757-4765.
23. Convit, J., Kerdel-Vargas, F., and Gordon, B. (1962). Disseminated aner-gic cutaneous leishmaniasis. Br. J. Dermatol. 74, 132-135.
24. Costa, D. L., Carregaro, V., Lima-Junior,D. S., Silva, N. M., Milanezi, C. M., Cardoso, C. R., Giudice, A., de Jesus, A. R., Carvalho, E. M., Almeida, R. P., and Silva, J. S. (2011). BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production. PLoS Negl. Trop. Dis. 5, e965. doi: 10.1371/journal. pntd.0000965.
25. Costa, J. M., Marsden, P. D., Llanos-Cuentas, E. A., Netto, E. M., Carvalho, E. M., Barral, A., Rosa, A. C., Cuba, C. C., Magalhaes, A. V., and Barreto, A. C. (1986). Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases. J. Trop. Med. Hyg. 89,319-323.
26. de Moura, T. R., Novais, F. O., Oliveira, E, Clarencio, J., Noronha, A., Barral, A.,Brodskyn, C., and de Oliveira, C.I. (2005). Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis. Infect. Immun. 73, 5827-5834.
27. de Moura, T. R., Oliveira, F., Novais, F. O., Miranda, J. C., Clarencio, J., Follador, I., Carvalho, E. M., Valen-zuela, J. G., Barral-Netto, M., Barral, A., Brodskyn, C., and de Oliveira, C. I. (2007). Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva. PLoS Negl. Trop. Dis. 1, e84. doi: 10.1371/ journal.pntd.0000084.
28. de Moura, T. R., Oliveira, F., Rodrigues, G. C., Carneiro, M. W., Fukutani, K. F., Novais, F. O., Miranda, J. C., Barral-Netto, M., Brodskyn, C., Barral, A., and de Oliveira, C. I. (2010). Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis. PLoS Negl. Trop. Dis. 4, e712. doi: 10.1371/journal. pntd.0000712.
29. de Souza-Neto, S. M., Carneiro, C. M., Vieira, L. Q., and Afonso, L. C. (2004). Leishmania braziliensis: partial control of experimental infection by interleukin-12 p40 deficient mice. Mem. Inst. Oswaldo Cruz. 99, 289-294.
30. DeKrey, G. K., Lima, H. C., and Titus, R. G. (1998). Analysis of the immune responses of mice to infection with Leishmania braziliensis. Infect. Immun. 66, 827-829.
31. Falcão, S. C., de Moura, T. R., Clarêncio, J., Brodskyn, C., Barral, A., and de Oliveira, C. I. (2012). The presence of Tregs does not preclude immunity to reinfection with Leishmania braziliensis. Int. J. for Parasitol. (in press).
32. Faria, D. R., Gollob, K. J., Barbosa, J. Jr., Schriefer, A., Machado, P. R., Lessa, H., Carvalho, L. P., Romano-Silva, M. A., de Jesus, A. R., Carvalho, E. M., and Dutra, W. O. (2005). Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect. Immun. 73, 7853-7859.
33. Faria, D. R., Souza, P. E., Duraes, F. V., Carvalho, E. M., Gollob, K. J., Machado, P. R., and Dutra, W. (2009). Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis. Parasite Immunol. 31, 432-439.
34. Figueroa, R. A., Lozano, L. E., Romero, I. C., Cardona, M. T., Prager, M., Pacheco, R., Diaz, Y. R., Tellez, J. A., and Saravia, N. G. (2009). Detection of Leishmania in unaffected mucosal tissues of patients with cutaneous leishmaniasis caused by Leishmania (Viannia) species. J. Infect. Dis. 200, 638-646.
35. Follador, I., Araujo, C., Bacellar, O., Araujo, C. B., Carvalho, L. P., Almeida, R. P., and Carvalho, E. M. (2002). Epidemiologic and immuno-logic findings for the subclinical form of Leishmania braziliensis infection. Clin. Infect. Dis. 34, E54-E58.
36. Gaze, S. T., Dutra, W. O., Lessa, M., Lessa, H., Guimaraes, L. H., Jesus, A. R., Carvalho, L. P., Machado, P., Carvalho, E. M., and Gollob, K. J. (2006). Mucosal leishmaniasis patients display an activated inflammatory T-cell phenotype associated with a nonbalanced monocyte population. Scand. J. Immunol. 63, 70-78.
37. Gomes, R., Teixeira, C., Teixeira, M. J., Oliveira, F., Menezes, M. J., Silva, C., de Oliveira, C. I., Miranda, J. C., Elnaiem, D. E., Kamhawi, S., Valenzuela, J. G., and Brodskyn, C. I. (2008). Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. Proc. Natl. Acad. Sci. U.S.A. 105, 7845-7850.
38. Guimaraes-Costa, A. B., Nascimento, M. T., Froment, G. S., Soares, R. P., Morgado, F. N., Conceicao-Silva, F., and Saraiva, E. M. (2009). Leishmania amazonensis promastig-otes induce and are killed by neu-trophil extracellular traps. Proc. Natl. Acad. Sci. U.S.A. 106, 6748-6753.
39. Indiani de Oliveira, C., Teixeira, M. J., Teixeira, C. R., Ramos de Jesus, J., Bomura Rosato, A., Santa da Silva, J., Brodskyn, C., Barral-Netto, M., and Barral, A. (2004). Leishmania braziliensis isolates differing at the genome level display distinctive features in BALB/c mice. Microbes Infect. 6, 977-984.
40. Ives, A., Ronet, C., Prevel, F., Ruzzante, G., Fuertes-Marraco, S., Schutz, F., Zangger, H., Revaz-Breton, M., Lye, L. F., Hickerson, S. M., Beverley, S. M., Acha-Orbea, H., Launois, P., Fasel, N., and Masina, S. (2011). Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis. Science 331, 775-778.
41. Jones, T. C., Johnson, W. D. Jr., Bar-retto, A. C., Lago, E., Badaro, R., Cerf, B., Reed, S. G., Netto, E. M., Tada, M. S., Franca, F., Wiese, K., Golightly, L., Fikrig, E., Costa, J. M. L., Cuba, C. C., and Marsden, P. D. (1987). Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J. Infect. Dis. 156, 73-83.
42. Keesen, T. S., Antonelli, L. R., Faria, D. R., Guimaraes, L. H., Bacellar, O., Carvalho, E. M., Dutra, W. O., and Gollob, K. J. (2011). CD4(+) T cells defined by their Vbeta T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis. Clin. Exp. Immunol. 165, 338-351.
43. Khouri, R., Bafica, A., Silva Mda, P., Noronha, A., Kolb, J. P., Wietzerbin, J., Barral, A., Barral-Netto, M., and Van Weyenbergh, J. (2009). IFN-beta impairs superoxide-dependent parasite killing in human macrophages: evidence for a deleterious role of SOD1 in cutaneous leishmaniasis. J. Immunol. 182,2525-2531.
44. Khouri, R., Novais, F., Santana, G., de Oliveira, C. I., Vannier dos Santos, M. A., Barral, A., Barral-Netto, M., and Van Weyenbergh, J. (2010). DETC induces Leishma-nia parasite killing in human in vitro and murine in vivo models: a promising therapeutic alternative in Leishmaniasis. PLoS ONE 5, e14394. doi:10.1371/journal.pone.0014394.
45. Lessa, H. A., Machado, P., Lima, F., Cruz, A. A., Bacellar, O., Guerreiro, J., and Carvalho, E. M. (2001). Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am. J. Trop. Med. Hyg. 65, 87-89.
46. Lima, H. C., and Titus, R. G. (1996). Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leish-mania braziliensis in BALB/c mice. Infect. Immun. 64, 5442-5445.
47. Lye, L. F., Owens, K., Shi, H., Murta, S. M., Vieira, A. C., Turco, S. J., Tschudi, C., Ullu, E., and Bever-ley, S. M. (2010). Retention and loss of RNA interference pathways in trypanosomatid protozoans. PLoS Pathog. 6, e1001161. doi: 10.1371/ journal.ppat.1001161.
48. Machado, P., Kanitakis, J., Almeida, R., Chalon, A., Araujo, C., and Carvalho, E. (2002). Evidence of in sittu citotoxicity in American cutaneous leishmaniasis. Eur. J. Dermatol. 12, 449-451.
49. Maioli, T. U., Takane, E., Arantes, R. M., Fietto, J. L., and Afonso, L. C. (2004). Immune response induced by New World Leishmania species in C57BL/6 mice. Parasitol. Res. 94,207-212.
50. Maretti-Mira, A. C., de Pinho Rodrigues, K. M., de Oliveira-Neto, M. P., Pirmez, C., and Craft, N. (2011). MMP-9 activity is induced by Leishmania braziliensis infection and correlates with mucosal leishmaniasis. Acta Trop. 119,160-164.
51. Maroof, A., Beattie, L., Zubairi, S., Svensson, M., Stager, S., and Kaye, P. M. (2008). Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function. Immunity 29,295-305.
52. Marsden, P. D. (1990). Mucocutaneous leishmaniasis. BMJ 301, 656-657.
53. Martins, L., Alexandrino, A., and Guimaraes, G. (2010). Detection of Leishmania braziliensis DNA in American tegumentary leishmaniasis patients. Rev. Saude Publica. 44, 571-574.
54. McFarlane, E., Perez, C., Charmoy, M., Allenbach, C., Carter, K. C., Alexander, J., and Tacchini-Cottier, R (2008). Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani. Infect. Immun. 76,532-541.
55. Mendes-Aguiar Cde, O., Gomes-Silva, A., Nunes, E. Jr., Pereira-Carvalho, R., Nogueira, R. S., Oliveira-Neto Mde, P., Bertho, A. L., and Da-Cruz, A. M. (2009). The skin homing receptor cutaneous leucocyte-associated antigen (CLA) is up-regulated by Leishmania antigens in T lymphocytes during active cutaneous leishmaniasis. Clin. Exp. Immunol. 157, 377-384.
56. Mendonca, M. G., de Brito, M. E., Rodrigues, E. H., Bandeira, V., Jar dim, M. L., and Abath, E G. (2004). Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure? J. Infect. Dis. 189, 1018-1023.
57. Menezes, M. J., Costa, D. J., Clarencio, J., Miranda, J. C., Barral, A., Barral-Netto, M., Brodskyn, C., and de Oliveira, C. I. (2008). Immunomod-ulation of human monocytes following exposure to Lutzomyia intermedia saliva. BMC Immunol. 9, 12. doi: 10.1186/1471-2172-9-12.
58. Miles, S. A., Conrad, S. M., Alves, R. G., Jeronimo, S. M., and Mosser, D. M. (2005). A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J. Exp. Med. 201, 747-754.
59. Miranda, J. C., Reis, E., Schriefer, A., Goncalves, M., Reis, M. G., Carvalho, L., Fernandes, O., Barral-Netto, M., and Barral, A. (2002). Frequency of infection of Lutzomyia phlebotomines with Leishmania braziliensis in a Brazilian endemic area as assessed by pinpoint capture and polymerase chain reaction. Mem. Inst. Oswaldo Cruz. 97, 185-188.
60. Norsworthy, N. B., Sun, J., Elnaiem, D., Lanzaro, G., and Soong, L. (2004). Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production. Infect. Immun. 72,1240-1247.
61. Novais, R O., Santiago, R. C., Bafica, A., Khouri, R., Afonso, L., Borges, V M., Brodskyn, C., Barral-Netto, M., Barral, A., and de Oliveira, C. I. (2009). Neutrophils and macrophages cooperate in host resistance against Leishmania braziliensis infection. J. Immunol. 183, 8088-8098.
62. Novoa, R., Bacellar, O., Nascimento, M., Cardoso, T. M., Ramasawmy, R., Oliveira, W. N., Schriefer, A., and Carvalho, E. M. (2011). IL-17 and regulatory cytokines (IL-10 and IL-27) in L. braziliensis infection. Parasite Immunol. 33,132-136.
63. Nylen, S., Maurya, R., Eidsmo, L., Manandhar, K. D., Sundar, S., and Sacks, D. (2007). Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J. Exp. Med. 204, 805-817.
64. Oliveira, F., Bafica, A., Rosato, A. B., Favali, C. B., Costa, J. M., Cafe, V., Barral-Netto, M., and Barral, A. (2011). Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis. Am. J. Trop. Med. Hyg. 85, 70-73.
65. Patterson, J. L. (1993). The current status of Leishmania RNA virus I. Parasitol. Today 9,135-136.
66. Peacock, C. S., Seeger, K., Harris, D., Murphy, L., Ruiz, J. C., Quail, M. A., Peters, N., Adlem, E., Tivey, A., Aslett, M., Kerhornou, A., Ivens, A., Fraser, A., Rajandream, M. A., Carver, T., Norbertczak, H., Chill-ingworth, T., Hance, Z., Jagels, K., Moule, S., Ormond, D., Rutter, S., Squares, R., Whitehead, S., Rabbi-nowitsch, E., Arrowsmith, C., White, B., Thurston, S., Bringaud, F., Bal-dauf, S. L., Faulconbridge, A., Jeffares, D., Depledge, D. P., Oyola, S. O., Hil-ley, J. D., Brito, L. O., Tosi, L. R., Barrell, B., Cruz, A. K., Mottram, J. C., Smith, D. F., and Berriman, M. (2007). Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat. Genet. 39, 839-847.
67. Pompeu, M. M., Brodskyn, C., Teix-eira, M. J., Clarencio, J., Van Weyen-berg, J., Coelho, I. C., Cardoso, S. A., Barral, A., and Barral-Netto, M. (2001). Differences in gamma inter-feron production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers. Infect. Immun. 69, 7453-7460.
68. Rebelo, J. M., Assuncao, A. N. Jr., Silva, O., and Moraes, J. L. (2010). Occurrence of sand flies (Diptera, Psychodidae) in leishmaniasis foci in an ecotourism area around the Lencois Maranhenses National Park, Brazil. Cad. Saude Publica. 26, 195-198.
69. Ribeiro-de-Jesus, A., Almeida, R. P., Lessa, H., Bacellar, O., and Carvalho, E. M. (1998). Cytokine profile and pathology in human leishmaniasis. Braz. I Med. Biol. Res. 31, 143-148.
70. Rocha, F. J., Schleicher, U., Mattner, J., Alber, G., and Bogdan, C. (2007). Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Vian-nia) braziliensis in mice. Infect. Immun. 75, 3823-3832.
71. Rohousova, I., Ozensoy, S., Ozbel, Y., and Volf, P. (2005). Detection of species-specific antibody response of humans and mice bitten by sand flies. Parasitology 130,493-499.
72. Ronet, C., Hauyon-La Torre, Y., Revaz-Breton, M., Mastelic, B., Tacchini-Cottier, F., Louis, J., and Launois, P. (2010) Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. J. Immunol. 184, 886-894.
73. Salay, G., Dorta, M. L., Santos, N. M., Mortara, R. A., Brodskyn, C., Oliveira, C. I., Barbieri, C. L., and Rodrigues, M. M. (2007). Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World. Clin. Vaccine Immunol. 14, 1173-1181.
74. Samuelson, J., Lerner, E., Tesh, R., and Titus, R. (1991). A mouse model of Leishmania braziliensis braziliensis infection produced by coinjection with sand fly saliva. J. Exp. Med. 173, 49-54.
75. Schubach, A., Haddad, F., Oliveira-Neto, M. P., Degrave, W., Pirmez, C., Grimaldi, G. Jr., and Fernandes, O. (1998). Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J. Infect. Dis. 178,911-914.
76. Shi, H., Chamond, N., Tschudi, C., and Ullu, E. (2004). Selection and characterization of RNA interference-deficient trypanosomes impaired in target mRNA degradation. Eukaryot. Cell 3,1445-1453.
77. Sousa Ade, Q., Parise, M. E., Pompeu, M. M., Coehlo Filho, J. M., Vascon-celos, I. A., Lima, J. W., Oliveira, E. G., Vasconcelos, A. W., David, J. R., and Maguire, J. H. (1995). Bubonic leishmaniasis: a common manifestation of Leishmania (Viannia) braziliensis infection in Ceara, Brazil. Am. J. Trop. Med. Hyg. 53, 380-385.
78. Stager, S., Maroof, A., Zubairi, S., Sanos, S. L., Kopf, M., and Kaye, P. M. (2006). Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells. Eur. J. Immunol. 36,1764-1771.
79. Svensson, M., Maroof, A., Ato, M., and Kaye, P. M. (2004). Stromal cells direct local differentiation of regulatory dendritic cells. Immunity 21, 805-816.
80. Tarr, P. I., Aline, R. E Jr., Smiley, B. L., Scholler, J., Keithly, J., and Stuart, K. (1988). LR1: a candidate RNA virus of Leishmania. Proc. Natl. Acad. Sci. U.S.A. 85, 9572-9575.
81. Tavares, N. M., Silva, R. A., Costa, D. J., Pitombo, M. A., Fukutani, K. E, Miranda, J. C., Valenzuela, J. G., Barral, A., de Oliveira, C. I., Barral-Netto, M., and Brodskyn, C. (2011). Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia. PLoS Negl. Trop. Dis. 5, e1169. doi: 10.1371/journal.pntd.0001169.
82. Teixeira, M. J., Fernandes, J. D., Teix-eira, C. R., Andrade, B. B., Pompeu, M. L., Santana da Silva, J., Brodskyn, C. I., Barral-Netto, M., and Barral, A. (2005). Distinct Leishmania braziliensis isolates induce different paces of chemokine expression patterns. Infect. Immun. 73, 1191-1195.
83. Thiakaki, M., Rohousova, I., Volfova, V., Volf, P., Chang, K. P., and Soteri-adou,K. (2005). Sandfly specificity of saliva-mediated protective immunity in Leishmania amazonensis-BALB/c mouse model. Microbes Infect. 7, 760-766.
84. Trinchieri, G., Pflanz, S., and Kastelein, R. A. (2003). The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19, 641-644.
85. Valenzuela, J. G., Belkaid, Y., Garfield, M. K., Mendez, S., Kamhawi, S., Rowton, E. D., Sacks, D. L., and Ribeiro, J. M. (2001). Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. J. Exp. Med. 194, 331-342.
86. Vargas-Inchaustegui, D. A., Hogg, A. E., Tulliano, G., Llanos-Cuentas, A., Arevalo, J., Endsley, J. J., and Soong, L. (2010). CXCL10 production by human monocytes in response to Leishmania braziliensis infection. Infect. Immun. 78, 301-308.
87. Vargas-Inchaustegui, D. A., Tai, W., Xin, L., Hogg, A. E., Corry, D. B., and Soong, L. (2009). Distinct roles for MyD88 and Toll-like receptor 2 during Leishmania braziliensis infection in mice. Infect. Immun. 77, 2948-2956.
88. Vargas-Inchaustegui, D. A., Xin, L., and Soong, L. (2008). Leishmania braziliensis infection induces dendritic cell activation, ISG15 transcription, and the generation of protective immune responses. J. Immunol. 180, 7537-7545.
89. Yoshimura, T., Takeda, A., Hamano, S., Miyazaki, Y., Kinjyo, I., Ishibashi, T., Yoshimura, A., and Yoshida, H. (2006). Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J. Immunol. 177, 5377-5385.